Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27831039 | 1.00 | TDP1 (0.48) | TDP1LMNAL3MBTL1PDE4AGSR | |
| SCHEMBL27487804 | 0.82 | TDP1 (0.46) | TDP1LMNAL3MBTL1PDE4AGSR | |
| SCHEMBL11096084 | 0.80 | LMNA (0.44) | TDP1LMNAL3MBTL1PDE4AGSR | |
| SCHEMBL11099297 | 0.80 | LMNA (0.44) | TDP1LMNAL3MBTL1PDE4AGSR | |
| SCHEMBL11096035 | 0.80 | LMNA (0.44) | TDP1LMNAL3MBTL1PDE4AGSR | |
| SCHEMBL18585681 | 0.76 | TDP1 (0.48) | TDP1LMNAL3MBTL1PDE4AGSR | |
| SCHEMBL1460202 | 0.76 | LMNA (0.39) | TDP1LMNAL3MBTL1PDE4AGSR | |
| Mannitol SCHEMBL10952803 | 0.75 | LMNA (0.61) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Mannitol SCHEMBL6690019 | 0.75 | LMNA (0.61) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Mannitol SCHEMBL29085543 | 0.75 | LMNA (0.61) | TDP1LMNAL3MBTL1PDE4AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1103316-A | Cyclodextrin and polymer based drug delivery system | INSITE VISION INC (US) | 1995-06-07 | — | — | CN | disclosed |